Literature DB >> 7998791

Use and misuse of statistics for epidemiological studies of multiple sclerosis.

P L Hibberd1.   

Abstract

Despite a vast literature on the epidemiology of multiple sclerosis, the cause of this disease remains elusive. The majority of the studies have focused on prevalence, so that a worldwide distribution of multiple sclerosis can now be mapped. Tantalizing apparent differences in prevalence have resulted in an abundance of hypotheses about risk factors for multiple sclerosis, none of which have been firmly established. This article reviews the difficulties inherent in the use of any type of descriptive study to investigate etiology of disease and provides an update of appropriate statistical methodology to analyze study results. The major focus is on the use of analytical study design, specifically the case-control study, to investigate a specific hypothesis about association between a risk factor and multiple sclerosis. An update on new epidemiological and statistical methodology to enhance the design of future case-control studies is presented. Future opportunities to study multiple sclerosis in new ways, such as in cohort studies or nested case-control studies, using large medical insurance and other types of health-related data bases, are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 7998791     DOI: 10.1002/ana.410360809

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Economic evaluation of multiple sclerosis in the UK, Germany and France.

Authors:  N Murphy; C Confavreux; J Haas; N König; E Roullet; M Sailer; M Swash; C Young; J L Mérot
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

Review 2.  The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment.

Authors:  Ceri J Phillips
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Assessing cost-effectiveness in the management of multiple sclerosis.

Authors:  Ceri J Phillips; Ioan Humphreys
Journal:  Clinicoecon Outcomes Res       Date:  2009-11-18

4.  Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran.

Authors:  Ali Imani; Farid Gharibi; Ali Khezri; Nasrin Joudyian; Koustuv Dalal
Journal:  BMC Neurol       Date:  2020-05-23       Impact factor: 2.474

5.  The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran.

Authors:  Farid Gharibi; Ali Imani; Koustuv Dalal
Journal:  BMC Health Serv Res       Date:  2021-03-20       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.